カテゴリー： Market Monitor Global, 世界, 医療/バイオ

睡眠障害治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Sleep Disorder Treatment Drugs Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8666 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月（※2025年版があります。お問い合わせください。） ◆ページ数：73 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Sleep Disorder Treatment Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの睡眠障害治療薬市場規模と予測を収録しています。・世界の睡眠障害治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の睡眠障害治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の睡眠障害治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「医療用医薬品」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

睡眠障害治療薬のグローバル主要企業は、Pfizer、 Sanofi、 Merck、 GlaxoSmithKline、 Koninklijke Philips、 Takeda Pharmaceutical Company、 Leva Pharmaceutical Industries、 Cardinal Health、 Becton Dickson and Company、 Natus Medicalorporatedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、睡眠障害治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の睡眠障害治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の睡眠障害治療薬市場：タイプ別市場シェア、2022年
・医療用医薬品、一般用医薬品、漢方薬

世界の睡眠障害治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の睡眠障害治療薬市場：用途別市場シェア、2022年
・病院、クリニック、研究センター、その他

世界の睡眠障害治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の睡眠障害治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における睡眠障害治療薬のグローバル売上、2018年-2023年
・主要企業における睡眠障害治療薬のグローバル売上シェア、2022年
・主要企業における睡眠障害治療薬のグローバル販売量、2018年-2023年
・主要企業における睡眠障害治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer、 Sanofi、 Merck、 GlaxoSmithKline、 Koninklijke Philips、 Takeda Pharmaceutical Company、 Leva Pharmaceutical Industries、 Cardinal Health、 Becton Dickson and Company、 Natus Medicalorporated

*************************************************************

・調査・分析レポートの概要
睡眠障害治療薬市場の定義
市場セグメント
世界の睡眠障害治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の睡眠障害治療薬市場規模
世界の睡眠障害治療薬市場規模：2022年 VS 2029年
世界の睡眠障害治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの睡眠障害治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の睡眠障害治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：医療用医薬品、一般用医薬品、漢方薬
睡眠障害治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、研究センター、その他
睡眠障害治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別睡眠障害治療薬市場規模 2022年と2029年
地域別睡眠障害治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer、 Sanofi、 Merck、 GlaxoSmithKline、 Koninklijke Philips、 Takeda Pharmaceutical Company、 Leva Pharmaceutical Industries、 Cardinal Health、 Becton Dickson and Company、 Natus Medicalorporated
...

Sleep Disorder Treatment Drugs are special treatments targeting on medical disorder in which the patient has difficulty with sleep maintenance or sleep initiation.
This report aims to provide a comprehensive presentation of the global market for Sleep Disorder Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep Disorder Treatment Drugs. This report contains market size and forecasts of Sleep Disorder Treatment Drugs in global, including the following market information:
Global Sleep Disorder Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Sleep Disorder Treatment Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Sleep Disorder Treatment Drugs companies in 2022 (%)
The global Sleep Disorder Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as increasing incidences of depression and other medical disorders, late night working schedule, busy lifestyle, lack of quality sleep, and rising geriatric population drive the market growth.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sleep Disorder Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sleep Disorder Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sleep Disorder Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Prescription-based Drugs
OTC Drugs
Herbal Drugs
Global Sleep Disorder Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sleep Disorder Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Research Centers
Others
Global Sleep Disorder Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Sleep Disorder Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sleep Disorder Treatment Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sleep Disorder Treatment Drugs revenues share in global market, 2022 (%)
Key companies Sleep Disorder Treatment Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Sleep Disorder Treatment Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Merck
GlaxoSmithKline
Koninklijke Philips
Takeda Pharmaceutical Company
Leva Pharmaceutical Industries
Cardinal Health
Becton Dickson and Company
Natus Medicalorporated
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sleep Disorder Treatment Drugs, market overview.
Chapter 2: Global Sleep Disorder Treatment Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Sleep Disorder Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sleep Disorder Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sleep Disorder Treatment Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Sleep Disorder Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sleep Disorder Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sleep Disorder Treatment Drugs Overall Market Size
2.1 Global Sleep Disorder Treatment Drugs Market Size: 2022 VS 2029
2.2 Global Sleep Disorder Treatment Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Sleep Disorder Treatment Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Sleep Disorder Treatment Drugs Players in Global Market
3.2 Top Global Sleep Disorder Treatment Drugs Companies Ranked by Revenue
3.3 Global Sleep Disorder Treatment Drugs Revenue by Companies
3.4 Global Sleep Disorder Treatment Drugs Sales by Companies
3.5 Global Sleep Disorder Treatment Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sleep Disorder Treatment Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sleep Disorder Treatment Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sleep Disorder Treatment Drugs Players in Global Market
3.8.1 List of Global Tier 1 Sleep Disorder Treatment Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Sleep Disorder Treatment Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Sleep Disorder Treatment Drugs Market Size Markets, 2022 & 2029
4.1.2 Prescription-based Drugs
4.1.3 OTC Drugs
4.1.4 Herbal Drugs
4.2 By Type – Global Sleep Disorder Treatment Drugs Revenue & Forecasts
4.2.1 By Type – Global Sleep Disorder Treatment Drugs Revenue, 2018-2023
4.2.2 By Type – Global Sleep Disorder Treatment Drugs Revenue, 2024-2029
4.2.3 By Type – Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Sleep Disorder Treatment Drugs Sales & Forecasts
4.3.1 By Type – Global Sleep Disorder Treatment Drugs Sales, 2018-2023
4.3.2 By Type – Global Sleep Disorder Treatment Drugs Sales, 2024-2029
4.3.3 By Type – Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Sleep Disorder Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sleep Disorder Treatment Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Centers
5.1.5 Others
5.2 By Application – Global Sleep Disorder Treatment Drugs Revenue & Forecasts
5.2.1 By Application – Global Sleep Disorder Treatment Drugs Revenue, 2018-2023
5.2.2 By Application – Global Sleep Disorder Treatment Drugs Revenue, 2024-2029
5.2.3 By Application – Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Sleep Disorder Treatment Drugs Sales & Forecasts
5.3.1 By Application – Global Sleep Disorder Treatment Drugs Sales, 2018-2023
5.3.2 By Application – Global Sleep Disorder Treatment Drugs Sales, 2024-2029
5.3.3 By Application – Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Sleep Disorder Treatment Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Sleep Disorder Treatment Drugs Market Size, 2022 & 2029
6.2 By Region – Global Sleep Disorder Treatment Drugs Revenue & Forecasts
6.2.1 By Region – Global Sleep Disorder Treatment Drugs Revenue, 2018-2023
6.2.2 By Region – Global Sleep Disorder Treatment Drugs Revenue, 2024-2029
6.2.3 By Region – Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Sleep Disorder Treatment Drugs Sales & Forecasts
6.3.1 By Region – Global Sleep Disorder Treatment Drugs Sales, 2018-2023
6.3.2 By Region – Global Sleep Disorder Treatment Drugs Sales, 2024-2029
6.3.3 By Region – Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Sleep Disorder Treatment Drugs Revenue, 2018-2029
6.4.2 By Country – North America Sleep Disorder Treatment Drugs Sales, 2018-2029
6.4.3 US Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.4.4 Canada Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.4.5 Mexico Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Sleep Disorder Treatment Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Sleep Disorder Treatment Drugs Sales, 2018-2029
6.5.3 Germany Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.4 France Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.5 U.K. Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.6 Italy Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.7 Russia Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.5.9 Benelux Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Sleep Disorder Treatment Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Sleep Disorder Treatment Drugs Sales, 2018-2029
6.6.3 China Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.6.4 Japan Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.6.5 South Korea Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.6.7 India Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Sleep Disorder Treatment Drugs Revenue, 2018-2029
6.7.2 By Country – South America Sleep Disorder Treatment Drugs Sales, 2018-2029
6.7.3 Brazil Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.7.4 Argentina Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Sleep Disorder Treatment Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Sleep Disorder Treatment Drugs Sales, 2018-2029
6.8.3 Turkey Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.8.4 Israel Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Sleep Disorder Treatment Drugs Market Size, 2018-2029
6.8.6 UAE Sleep Disorder Treatment Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Sleep Disorder Treatment Drugs Major Product Offerings
7.1.4 Pfizer Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Sleep Disorder Treatment Drugs Major Product Offerings
7.2.4 Sanofi Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Sleep Disorder Treatment Drugs Major Product Offerings
7.3.4 Merck Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Sleep Disorder Treatment Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Koninklijke Philips
7.5.1 Koninklijke Philips Company Summary
7.5.2 Koninklijke Philips Business Overview
7.5.3 Koninklijke Philips Sleep Disorder Treatment Drugs Major Product Offerings
7.5.4 Koninklijke Philips Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Koninklijke Philips Key News & Latest Developments
7.6 Takeda Pharmaceutical Company
7.6.1 Takeda Pharmaceutical Company Company Summary
7.6.2 Takeda Pharmaceutical Company Business Overview
7.6.3 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.7 Leva Pharmaceutical Industries
7.7.1 Leva Pharmaceutical Industries Company Summary
7.7.2 Leva Pharmaceutical Industries Business Overview
7.7.3 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Major Product Offerings
7.7.4 Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Leva Pharmaceutical Industries Key News & Latest Developments
7.8 Cardinal Health
7.8.1 Cardinal Health Company Summary
7.8.2 Cardinal Health Business Overview
7.8.3 Cardinal Health Sleep Disorder Treatment Drugs Major Product Offerings
7.8.4 Cardinal Health Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Cardinal Health Key News & Latest Developments
7.9 Becton Dickson and Company
7.9.1 Becton Dickson and Company Company Summary
7.9.2 Becton Dickson and Company Business Overview
7.9.3 Becton Dickson and Company Sleep Disorder Treatment Drugs Major Product Offerings
7.9.4 Becton Dickson and Company Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Becton Dickson and Company Key News & Latest Developments
7.10 Natus Medicalorporated
7.10.1 Natus Medicalorporated Company Summary
7.10.2 Natus Medicalorporated Business Overview
7.10.3 Natus Medicalorporated Sleep Disorder Treatment Drugs Major Product Offerings
7.10.4 Natus Medicalorporated Sleep Disorder Treatment Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Natus Medicalorporated Key News & Latest Developments
8 Global Sleep Disorder Treatment Drugs Production Capacity, Analysis
8.1 Global Sleep Disorder Treatment Drugs Production Capacity, 2018-2029
8.2 Sleep Disorder Treatment Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Sleep Disorder Treatment Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sleep Disorder Treatment Drugs Supply Chain Analysis
10.1 Sleep Disorder Treatment Drugs Industry Value Chain
10.2 Sleep Disorder Treatment Drugs Upstream Market
10.3 Sleep Disorder Treatment Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sleep Disorder Treatment Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Sleep Disorder Treatment Drugs in Global Market
Table 2. Top Sleep Disorder Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sleep Disorder Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Sleep Disorder Treatment Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Sleep Disorder Treatment Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Sleep Disorder Treatment Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Sleep Disorder Treatment Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Sleep Disorder Treatment Drugs Product Type
Table 9. List of Global Tier 1 Sleep Disorder Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sleep Disorder Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Sleep Disorder Treatment Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Sleep Disorder Treatment Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Sleep Disorder Treatment Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Sleep Disorder Treatment Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Sleep Disorder Treatment Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Sleep Disorder Treatment Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Sleep Disorder Treatment Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Sleep Disorder Treatment Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Sleep Disorder Treatment Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Sleep Disorder Treatment Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Sleep Disorder Treatment Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Sleep Disorder Treatment Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Sleep Disorder Treatment Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Sleep Disorder Treatment Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Sleep Disorder Treatment Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Sales, (K Units), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Sleep Disorder Treatment Drugs Product Offerings
Table 48. Pfizer Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Sanofi Company Summary
Table 51. Sanofi Sleep Disorder Treatment Drugs Product Offerings
Table 52. Sanofi Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Sanofi Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Sleep Disorder Treatment Drugs Product Offerings
Table 56. Merck Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Sleep Disorder Treatment Drugs Product Offerings
Table 60. GlaxoSmithKline Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. Koninklijke Philips Company Summary
Table 63. Koninklijke Philips Sleep Disorder Treatment Drugs Product Offerings
Table 64. Koninklijke Philips Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Koninklijke Philips Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Company Summary
Table 67. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Product Offerings
Table 68. Takeda Pharmaceutical Company Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Takeda Pharmaceutical Company Key News & Latest Developments
Table 70. Leva Pharmaceutical Industries Company Summary
Table 71. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Product Offerings
Table 72. Leva Pharmaceutical Industries Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Leva Pharmaceutical Industries Key News & Latest Developments
Table 74. Cardinal Health Company Summary
Table 75. Cardinal Health Sleep Disorder Treatment Drugs Product Offerings
Table 76. Cardinal Health Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Cardinal Health Key News & Latest Developments
Table 78. Becton Dickson and Company Company Summary
Table 79. Becton Dickson and Company Sleep Disorder Treatment Drugs Product Offerings
Table 80. Becton Dickson and Company Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Becton Dickson and Company Key News & Latest Developments
Table 82. Natus Medicalorporated Company Summary
Table 83. Natus Medicalorporated Sleep Disorder Treatment Drugs Product Offerings
Table 84. Natus Medicalorporated Sleep Disorder Treatment Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Natus Medicalorporated Key News & Latest Developments
Table 86. Sleep Disorder Treatment Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Sleep Disorder Treatment Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Sleep Disorder Treatment Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Sleep Disorder Treatment Drugs Production by Region, 2024-2029 (K Units)
Table 90. Sleep Disorder Treatment Drugs Market Opportunities & Trends in Global Market
Table 91. Sleep Disorder Treatment Drugs Market Drivers in Global Market
Table 92. Sleep Disorder Treatment Drugs Market Restraints in Global Market
Table 93. Sleep Disorder Treatment Drugs Raw Materials
Table 94. Sleep Disorder Treatment Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Sleep Disorder Treatment Drugs Downstream
Table 96. Sleep Disorder Treatment Drugs Downstream Clients in Global Market
Table 97. Sleep Disorder Treatment Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sleep Disorder Treatment Drugs Segment by Type in 2022
Figure 2. Sleep Disorder Treatment Drugs Segment by Application in 2022
Figure 3. Global Sleep Disorder Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sleep Disorder Treatment Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Sleep Disorder Treatment Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Sleep Disorder Treatment Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Sleep Disorder Treatment Drugs Revenue in 2022
Figure 9. By Type - Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Sleep Disorder Treatment Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Sleep Disorder Treatment Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 23. US Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 28. Germany Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 37. China Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Sleep Disorder Treatment Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Sleep Disorder Treatment Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Sleep Disorder Treatment Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Sleep Disorder Treatment Drugs by Region, 2022 VS 2029
Figure 54. Sleep Disorder Treatment Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

睡眠障害治療薬は、睡眠に関する問題を改善するために用いられる医薬品であり、様々な種類の睡眠障害に対して処方されます。睡眠は私たちの健康や日常生活において非常に重要な役割を果たしているため、睡眠障害があると生活の質が大きく損なわれることがあります。したがって、適切な治療薬を用いることが求められます。

まず、睡眠障害とは一般的に、入眠困難や中途覚醒、過剰な眠気などを伴うものとして定義されます。これには、一般的な不眠症、睡眠時無呼吸症候群、ナルコレプシーなどが含まれます。これらの障害は、ストレスや不安、生活習慣、病気の影響など多岐にわたる要因によって引き起こされます。

睡眠障害治療薬は、その作用機序や成分によっていくつかの種類に分類されます。一般的には、バルビツール酸系薬物やベンゾジアゼピン系薬物、非ベンゾジアゼピン系薬物などが挙げられます。バルビツール酸系薬物は、従来の睡眠薬として使われてきましたが、副作用が強いため、現在ではあまり使用されていません。ベンゾジアゼピン系薬物は、睡眠の導入を助ける作用があり、多くの種類が存在します。これらの薬は、短期間の使用が推奨されますが、依存症や耐性の形成が懸念されます。

非ベンゾジアゼピン系薬物は、より新しいタイプの睡眠薬であり、ベンゾジアゼピンに比べて依存性が少ないとされるため、最近では広く用いられています。たとえば、ゾルピデムやエスゾピクロンなどがこれに当たります。これらは、睡眠導入を促進し、中途覚醒を抑える効果があるとされています。

他にも、メラトニン受容体作動薬や抗うつ薬、抗ヒスタミン薬も睡眠障害の治療に用いられることがあります。メラトニン受容体作動薬は、体内時計の調整を助けるため、特に時差ぼけや不規則な生活による睡眠障害に効果的です。抗うつ薬は、不眠症がうつ病の症状として現れる場合に、うつ病の治療とともに睡眠を改善するために用いられます。抗ヒスタミン薬は、アレルギー治療薬として広く使用されていますが、その副作用として眠気を引き起こすことから、一時的な不眠症の治療にも利用されることがあります。

薬物治療の他にも、認知行動療法（CBT-I）が不眠症治療において推奨されることがあります。このアプローチは、睡眠に関する考え方や行動を見直し、より良い睡眠習慣を築く手助けをするものです。睡眠衛生教育やリラクゼーション技法も併用されることが多く、薬物療法と並行して行うことで、より効果的な結果が期待できます。

睡眠障害治療薬の使用に際しては、副作用や相互作用に十分な注意が必要です。特に高齢者の場合、薬の副作用が表れやすく、転倒などのリスクが増加するため、慎重な投与が求められます。また、長期間にわたる薬の使用は、依存症や耐性のリスクを伴うため、医師の指導の下で使用することが不可欠です。

最近では、テクノロジーの進展により、睡眠障害の治療に関する新たなアプローチも登場しています。例えば、アプリやウェアラブルデバイスを用いた睡眠トラッキングが広がり、個々の睡眠パターンを把握することで、より効果的な治療方法を見つける手助けとなります。また、光療法や音響療法といった非侵襲的な治療法も注目されています。

まとめると、睡眠障害治療薬は、睡眠の質を改善するために用いられる多様な薬剤群であり、それぞれに特徴や用途があります。適切な薬の選択や治療方法に関しては、専門的な知識を持つ医療従事者の指導を受けることが重要です。また、薬物療法とともにライフスタイルの改善や心理的なアプローチを併用することで、より良い睡眠を得ることが可能となります。睡眠の重要性を再認識し、睡眠障害に対する理解を深め、効果的な治療法を見つけることが、健康的な生活の基盤となるでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 睡眠障害治療薬の世界市場見通し2023年-2029年(Sleep Disorder Treatment Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

睡眠障害治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp